skip to Main Content
Blue Cross Blue Shield Of Michigan Medical Policy Updates

BCBS Michigan Medical Policy Updates – July 2018

Click here to view the Blue Cross Blue Shield Michigan Medical Policy Updates » July 2018 Medical Policy Updates: Bavencio ®(avelumab) Bendeka™(bendamustine hydrochloride injection) EntyvioTM(vedolizumab) Krystexxa®(pegloticase) Kymriah™ (tisagenlecleucel), Yescarta™ (axicabtagene ciloleucel) Kymriah™ (tisagenlecleucel), Yescarta™ (axicabtagene ciloleucel) Minimally Invasive Lumbar Interbody…

Read More
Highmark Blue Cross Blue Shield

Highmark BCBS Medical Policy Updates – May 2018

Click here to the view the Highmark Blue Cross Blue Shield Medical Policy Updates » May 2018 Medical Policy Updates: Abatacept (Orencia) Agalsidase beta (Fabrazyme) Alglucosidase alfa (Lumizyme) Alpha1-Proteinase Inhibitor Infusions Anthrax Immunization and Treatment Assistant Surgery Eligibility Criteria Assisted…

Read More
Moda Health Plan August 2017 Medical Policy Updates

Moda Health Plan Pharmacy Policy Updates – May 2018

Click here to view the Moda Health Plan Pharmacy Policy Updates » April 2018 Pharmacy Policy Updates: Abraxane® (paclitaxel protein-bound particles) Alimta® (pemetrexed) Aranesp® (darbepoetin alfa) Erythropoiesis Stimulating Agents (ESAs): Avastin® (bevacizumab) Bavencio® (avelumab) Bendeka™ (bendamustine hcl) Beleodaq™ (belinostat) Colony…

Read More
Blue Cross Blue Shield Kansas Medical Policy Updates

BCBS Kansas Medical Policy Updates – May 2018

Click here to view the Blue Cross Blue Shield Kansas Medical Policy Updates » May 2018 Medical Policy Updates: Ampyra™ (dalfampridine) Injectable Asthma Agents Insulin Combination Agents (Soliqua, Xultophy) Opioids, Extended Release (ER) Spinraza™ (nusinersen) VMAT2 Inhibitors Xolair® (omalizumab) Xyrem®…

Read More
Aetna Medical Policy Updates

Aetna Medical Policy Updates – May 2018

Click here to view the Aetna Medical Policy Updates » May 2018 Medical Policy Updates: Actinic Keratoses Treatments Adalimumab (Humira) Alpha 1-Antitrypsin Inhibitor Therapy Antineoplaston Therapy and Sodium Phenylbutyrate Back Pain - Invasive Procedures Brentuximab (Adcetris) Cardiac Event Monitors Certolizumab…

Read More
Humana Medical Policy Updates

Humana Pharmacy Policy Updates – May 2018

Click here to view the Humana Pharmacy Policy Updates » May 2018 Pharmacy Policy Updates: Actemra® (tocilizumab) Intravenous Adcirca® (tadalafil) Afinitor® (everolimus)/Afinitor Disperz® (everolimus tablets for oral suspension) Asthma Interleukin Inhibitors (Cinqair, Nucala, Fasenra) Austedo™ (deutetrabenazine) Avastin® (bevacizumab) BPH Agents…

Read More
Back To Top